Moxifloxacin Stada (Moxifloxacin)

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in the respiratory, skin and intra‑abdominal systems.

• Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves clinical outcomes.
• Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
• Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications.
• Skin and skin structure infections: eliminates Gram‑negative and Gram‑positive organisms.
• Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic bacteria.

• Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to these targets, the drug prevents bacterial DNA synthesis and transcription, leading to bactericidal activity against a wide range of Gram‑positive and Gram‑negative organisms.

Moxifloxacin may cause adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools, occasionally watery.
• Headache: transient cranial discomfort.
• Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or swelling, especially in the Achilles.
• QT interval prolongation: risk of cardiac arrhythmias, monitor ECG in susceptible patients.
• Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

Before prescribing Moxifloxacin, clinicians should consider several safety measures.

• Renal function assessment: adjust therapy in patients with impaired clearance.
• Tendon monitoring: advise patients to report tendon pain or inflammation promptly.
• QT prolongation risk: avoid use with other QT‑prolonging agents and in patients with known cardiac conduction disorders.
• Elderly caution: increased susceptibility to adverse events; monitor closely.
• Discontinue on severe hypersensitivity: stop treatment if signs of anaphylaxis appear.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Moxifloxacin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: reduce absorption of the antibiotic.
• Warfarin: may enhance anticoagulant effect and increase bleeding risk.
• Theophylline: can raise serum theophylline concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation.
• Systemic corticosteroids: combined use may raise the chance of tendon disorders.